AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4797 out of 5301 analysts
Average Return
-4.19%
Win Rate
38%9 out of 24
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +174.75% | $16.20 | $44.51 | 2025-08-07 - 2026-06-18 | Buy |
Annexon IncANNX | +100.82% | $2.44 | $4.90 | 2025-08-15 - 2026-06-18 | Buy |
Avidity Biosciences IncRNAM | +56.46% | $44.74 | $70.00 | 2025-09-12 - 2025-10-27 | Buy |
Maze Therapeutics IncMAZE | +45.58% | $17.64 | $25.68 | 2025-07-23 - 2026-06-18 | Buy |
Dyne Therapeutics IncDYN | +35.62% | $14.60 | $19.80 | 2026-03-03 - 2026-06-18 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | 5 | Buy | $70.00 | +57.27% | Maintains | 11 days ago |
Maze Therapeutics IncMAZE | 5 | Buy | $110.00 | +328.35% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 3 | Buy | $50.00 | +152.53% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $37.00 | +71.14% | Reiterates | 5 months ago |
Stoke Therapeutics IncSTOK | 1 | Buy | $50.00 | +61.29% | Maintains | 6 months ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +1,017.32% | Maintains | 7 months ago |
Avidity Biosciences IncRNAM | 2 | Hold | $72.00 | +388.14% | Downgrades | 8 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +572.27% | Maintains | 8 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +2,728.85% | Initiates Coverage On | 9 months ago |
Annexon IncANNX | 1 | Buy | $14.00 | +185.71% | Reiterates | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.